Triple

T17871410
Position Surface form Disambiguated ID Type / Status
Subject Alnylam Pharmaceuticals, Inc. E446844 entity
Predicate foundedBy P104 FINISHED
Object David R. Corey — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: David R. Corey | Statement: [Alnylam Pharmaceuticals, Inc., foundedBy, David R. Corey]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: David R. Corey
Context triple: [Alnylam Pharmaceuticals, Inc., foundedBy, David R. Corey]
  • A. Michael V. Drake
    Michael V. Drake is an American academic leader and physician who has served as president of both The Ohio State University and the University of California system.
  • B. Stephen M. Kellen
    Stephen M. Kellen was a prominent financier and philanthropist known for his leadership at Arnhold and S. Bleichroeder and his significant support of cultural and educational institutions.
  • C. Brett M. Reed
    Brett M. Reed is a film editor best known for his work on the 2010 action movie "The Expendables."
  • D. David Reiman
    David Reiman is a researcher who contributed as a co-author to the landmark 2021 Nature paper by Jumper et al. describing the AlphaFold protein structure prediction system.
  • E. Christopher B. Duncan
    Christopher B. Duncan is an American actor best known for his comedic television roles, including portrayals of presidential and authority figures.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: David R. Corey
Target entity description: David R. Corey is a biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals, a pioneering company in RNA interference–based therapeutics.
  • A. Michael V. Drake
    Michael V. Drake is an American academic leader and physician who has served as president of both The Ohio State University and the University of California system.
  • B. Stephen M. Kellen
    Stephen M. Kellen was a prominent financier and philanthropist known for his leadership at Arnhold and S. Bleichroeder and his significant support of cultural and educational institutions.
  • C. Brett M. Reed
    Brett M. Reed is a film editor best known for his work on the 2010 action movie "The Expendables."
  • D. David Reiman
    David Reiman is a researcher who contributed as a co-author to the landmark 2021 Nature paper by Jumper et al. describing the AlphaFold protein structure prediction system.
  • E. Christopher B. Duncan
    Christopher B. Duncan is an American actor best known for his comedic television roles, including portrayals of presidential and authority figures.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8b9f4c22c819093c2680434472894 completed April 10, 2026, 8:51 a.m.
NER Named-entity recognition batch_69e49aa30ff8819090c51c1d7767e952 completed April 19, 2026, 9:04 a.m.
Created at: April 10, 2026, 10:18 a.m.